Strong Revenue Growth
Consolidated total revenue for the third quarter of 2025 was $347.1 million, an increase of 43.3% compared to $242.2 million in the prior year period.
DBM Global Backlog Increase
DBM Global's adjusted backlog increased by approximately $500 million to just over $1.6 billion since the end of 2024.
MediBeacon Regulatory Approval
MediBeacon received full regulatory approval from China's National Medical Products Administration for its Lumitrace injection, unlocking access to a critical healthcare market.
R2 Revenue and Sales Growth
R2's year-to-date revenues increased by 65% over the same period last year, with outside North America revenue surging 206% and system sales increasing by 392%.
Spectrum Content Portfolio Expansion
Spectrum strengthened its content portfolio with new network launches, including Lionsgate's MovieSphere Gold Channel and Sports First, reaching 45 U.S. markets.